Prajwal's 'suitcase' remark was not aimed at me: Kumaraswamy

Mangaluru, Feb 16: An elderly woman from Tamil Nadu was on Saturday reunited with her daughter and son after 14 years at the Mangaluru's White Doves destitute home.

"Mary only knew her name when she came here 10 years ago. Recently, she told us about her home town," Corrine Rusquinha, founder of White Doves told media.
Mary had gone missing 14 years ago from her hometown Kortampet in Tamil Nadu.

"Ten years ago, she was spotted by Mangaluru police who brought her to White Doves home late one evening. Initially, she could only speak Tamil, so it was presumed she was from Tamil Nadu. She was on psychiatric treatment," Rusquinha said.

A few days back, a visiting priest at the White Doves home spoke to Mary in Tamil and asked about her hometown.

"Surprisingly, she could recall the name of her hometown, following which the visiting priest contacted the pastor at Kortampet. Mary's family, including her daughter Gnana Anthony, who is a paramedic student in Coimbatore, was informed about Mary," she said.

Soon after, Gnana and her elder brother came to Mangaluru to take their mother back to their home.

Mary's husband Jhonson, who worked as a cook, had died within a year of losing his wife.

Jan 21: Info Edge (India)'s shareholding in Zomato reduces to 22.71%; Uber receives 9.99% stake in Zomato.

Info Edge (India) announced that Zomato Media (Zomato) has signed a definitive agreement to acquire Uber's food delivery business in India (Uber) in an all-stock transaction, which gives Uber 9.99% ownership in Zomato.

Uber Eats in India will discontinue operations and direct restaurants, delivery partners, and users of the Uber Eats apps to the Zomato platform, effective 21 January 2020.

Upon closing of said acquisition, the company's shareholding in Zomato shall stand reduced to about 22. 71 % on fully converted & diluted basis.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.